The previously-unknown condition, dubbed 'post-vaccination syndrome' (PVS), can persist years after taking the jabs - made by ...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...

SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to ...

Kentucky lawmakers are looking to merge the "Make America Healthy Again" — sometimes called MAHA — movement with state health ...

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Amid a torrent of troubling headlines, FT Edit brings you eight things to look forward to over the coming months ...

mRNA vaccination against SARS-CoV-2 was tied to a 57% and 73% lower risk of having at least one or two long-COVID symptoms, ...